← Back to Search

Behavioral Intervention

Exercise Intervention for Blood Cancer Patients Post-Transplant

N/A

Recruiting

Research Sponsored by Medical College of Wisconsin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

Scheduled to receive an alloBMT

Must not have

Inability to complete 15 minutes walking unassisted

Timeline

Screening 3 weeks

Treatment Varies

Follow Up cumulative percent from day 1 through discharge from hospital, on average day 30

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test if giving patients with blood cancer who are getting a bone marrow transplant a Fitbit-like device and app can help remind them to move around during their hospital stay so they can recover

Who is the study for?

This trial is for adults over 18 with blood cancers who are about to have a bone marrow transplant. They need their doctor's okay to join and must be able to walk for 15 minutes without help.

What is being tested?

The study tests if using wearable devices like a Fitbit, along with a custom smartphone app that reminds patients to move, helps recovery during the hospital stay after a bone marrow transplant.

What are the potential side effects?

Since this trial involves exercise intervention through reminders from an app and wearable device, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for a bone marrow transplant from a donor.

Select...

I have been diagnosed with a blood cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot walk for 15 minutes without help.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ cumulative percent from day 1 through discharge from hospital, on average day 30

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~cumulative percent from day 1 through discharge from hospital, on average day 30

This trial's timeline: 3 weeks for screening, Varies for treatment, and cumulative percent from day 1 through discharge from hospital, on average day 30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Patient feedback from participation in the study

Pilot evaluation of intervention efficacy

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Reminders to exercise through cues provided by wearable device + custom smartphone applicationExperimental Treatment1 Intervention

Each participant receives 2 wearable devices and custom smartphone application. Participants will wear an activity monitor on their non-dominant wrist and contralateral ankle. Post-transplant inpatient days \~3-10, participants will schedule three cued exercise sessions each day using the smartphone application. At the scheduled time, the wearable devices will vibrate to indicate "time to exercise" and participants are encouraged to complete an exercise task for 15 minutes. Post-transplant inpatient hospital days \~1-2 and post-transplant inpatient hospital days \~11 until discharge patients will wear the devices but will not receive any cues. During these days, the monitors will only be measuring their movement without any intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

exercise intervention

2013

N/A

~1060

0 / 4Eligibility criteria met